BioSpace News Archive

The higher doses of type 2 diabetes drug Trulicity significantly reduced A1C and also showed superiority in weight reduction. Here’s everything you should know about the drug.

Encoded said its approach to gene therapy will address key limitations of current gene therapy technology and unlock new treatment opportunities.

The award provides priority admission or a one-year renewal for lab bench space and access to core facilities at the MBC BioLabs life sciences incubator.

NOXXON Pharma N.V. hereby announces the launch and terms of a share capital increase with shareholders’ preferential rights for an amount of up to € 3.9 million.

The Rotterdam headquartered diagnostics company has been granted CAP accreditation, following its CLIA certification in December 2018 and became the first Dutch scale-up with a CAP and CLIA certified clinical laboratory in San Diego, joining an elite group of globally recognized facilities that operate at the highest level of quality laboratory standards.

Evotec SE announced that the Company successfully issued a Schuldschein of EUR 250 m on the capital market.

Pharnext SA announced the appointment of Peter Collum as Chief Financial Officer and Chief Business Officer.

Global Blood Therapeutics, Inc. announced the pricing of its underwritten public offering of 3,375,527 shares of its common stock for gross proceeds of approximately $200.0 million, before deducting the underwriting discounts and commissions and other estimated offering expenses payable by GBT.

Scientists created a protein cocktail that helped repair cardiac tissue. They believe it may potentially decrease many of the complications associated with stem cell transplantation.

“This round of financing is a clear demonstration of confidence in our strategic direction and ability to disrupt the electrophysiology space by delivering advanced, innovative technologies to our customers,” stated Vince Burgess, Acutus Medical’s chief executive officer.